Suppr超能文献

用于减轻电休克诱发的顺行性和逆行性记忆缺失的草药药物治疗。

Herbal pharmacotherapy for the attenuation of electroconvulsive shock-induced anterograde and retrograde amnestic deficits.

作者信息

Faruqi S, Andrade C, Ramteke S, Joseph J, Venkataraman B V, Naga Rani M A

机构信息

Department of Pharmacology, St. John's Medical College, Bangalore, India.

出版信息

Convuls Ther. 1995 Dec;11(4):241-7.

PMID:8919574
Abstract

BR-16A is an herbal (non-allopathic) medication used in India to enhance cognition. Sixty adult male Sprague Dawley rats received either BR-16A (200 mg/kg/day) or vehicle alone for 16 days. During the first 7 days, the rats were trained in a spatial memory task using the Hebb Williams complex maze. Once a day for the next 2 days, rats in BR-16A and control groups received either true or sham electroconvulsive shock (ECS). During the last 7 days of the study, the rats were reexposed to the maze to assess recall of pre-ECS training and to evaluate further improvement in learning scores. BR-16A-treated rats performed better than controls both before and after ECS. It is concluded that BR-16A facilitates learning and that this effect extends to a protection against ECS-induced anterograde and retrograde amnesia. BR-16A may hence hold promise in the restriction of ECT-induced cognitive compromise. An unexpected observation in this study was that BR-16A attenuated seizure duration; implications and mechanisms are discussed.

摘要

BR - 16A是一种在印度用于增强认知的草药(非对抗疗法)药物。60只成年雄性斯普拉格 - 道利大鼠接受BR - 16A(200毫克/千克/天)或仅接受赋形剂,持续16天。在最初的7天里,使用赫布 - 威廉姆斯复杂迷宫对大鼠进行空间记忆任务训练。在接下来的2天里,BR - 16A组和对照组的大鼠每天接受一次真电惊厥休克(ECS)或假电惊厥休克。在研究的最后7天,让大鼠再次进入迷宫,以评估对电惊厥休克前训练的记忆,并评估学习分数的进一步提高。接受BR - 16A治疗的大鼠在电惊厥休克前后的表现均优于对照组。得出的结论是,BR - 16A促进学习,并且这种作用扩展到对电惊厥休克诱导的顺行性和逆行性失忆的保护。因此,BR - 16A在限制电休克疗法引起的认知损害方面可能具有前景。本研究中一个意外的观察结果是,BR - 16A缩短了癫痫发作持续时间;文中讨论了其意义和机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验